| Primary |
| Menopause |
35.5% |
| Hormone Replacement Therapy |
30.0% |
| Menopausal Symptoms |
5.5% |
| Hypertension |
3.2% |
| Amnesia |
2.7% |
| Hysterectomy |
2.7% |
| Night Sweats |
2.7% |
| Prophylaxis |
2.7% |
| Hot Flush |
2.3% |
| Anxiety |
1.8% |
| Chills |
1.8% |
| Affective Disorder |
1.4% |
| Oophorectomy |
1.4% |
| Rash |
1.4% |
| Systemic Lupus Erythematosus |
1.4% |
| Convulsion |
0.9% |
| Infection |
0.9% |
| Pain |
0.9% |
| Ankylosing Spondylitis |
0.5% |
| Bladder Discomfort |
0.5% |
|
| Weight Decreased |
10.9% |
| White Blood Cell Count Decreased |
8.7% |
| Wound Closure |
8.7% |
| Pulmonary Embolism |
6.5% |
| Scar |
6.5% |
| Uterine Leiomyoma |
6.5% |
| Uterine Prolapse |
6.5% |
| Breast Cancer |
4.3% |
| Deafness |
4.3% |
| Mastectomy |
4.3% |
| Oedema Peripheral |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Progesterone Receptor Assay Positive |
4.3% |
| Tremor |
4.3% |
| Wound Drainage |
4.3% |
| Alopecia |
2.2% |
| Blood Pressure Increased |
2.2% |
| Breast Mass |
2.2% |
| Breast Operation |
2.2% |
| Gallbladder Disorder |
2.2% |
|
| Secondary |
| Hormone Replacement Therapy |
76.9% |
| Menopause |
10.7% |
| Menopausal Symptoms |
3.3% |
| Drug Use For Unknown Indication |
1.5% |
| Hot Flush |
1.0% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Hypertension |
0.8% |
| Oestrogen Replacement Therapy |
0.7% |
| Osteoporosis Prophylaxis |
0.5% |
| Seasonal Allergy |
0.5% |
| Cardiac Disorder |
0.5% |
| Ill-defined Disorder |
0.5% |
| Diabetes Mellitus |
0.4% |
| Menorrhagia |
0.4% |
| Hypersensitivity |
0.3% |
| Fibromyalgia |
0.3% |
| Glaucoma |
0.3% |
| Anxiety |
0.3% |
| Bipolar Disorder |
0.2% |
| Depression |
0.2% |
|
| Breast Cancer Female |
42.4% |
| Breast Cancer |
24.3% |
| Uterine Leiomyoma |
4.7% |
| Weight Decreased |
3.9% |
| Breast Cancer In Situ |
2.7% |
| Breast Cancer Metastatic |
2.7% |
| Polymedication |
2.4% |
| Vision Blurred |
2.4% |
| Ovarian Cancer |
2.0% |
| Ventricular Extrasystoles |
1.6% |
| Vertigo |
1.6% |
| Wound Closure |
1.6% |
| Deep Vein Thrombosis |
1.2% |
| Ovarian Cyst |
1.2% |
| Surgery |
1.2% |
| Tremor |
1.2% |
| Cerebrovascular Accident |
0.8% |
| Coronary Artery Disease |
0.8% |
| Deafness |
0.8% |
| Injury |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.3% |
| Drug Use For Unknown Indication |
13.6% |
| Hormone Replacement Therapy |
7.8% |
| Osteoporosis |
6.6% |
| Hypothyroidism |
5.3% |
| Pain |
5.3% |
| Depression |
5.0% |
| Rheumatoid Arthritis |
4.7% |
| Blood Cholesterol Increased |
3.6% |
| Prostate Cancer |
3.0% |
| Crohn's Disease |
2.8% |
| Hypertension |
2.6% |
| Anxiety |
2.6% |
| Hepatitis C |
2.6% |
| Insomnia |
2.4% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Osteopenia |
2.0% |
| Psoriasis |
2.0% |
| Multiple Sclerosis |
1.8% |
| Asthma |
1.8% |
|
| Weight Increased |
15.9% |
| Vomiting |
7.7% |
| Weight Decreased |
6.6% |
| Wound Infection Staphylococcal |
6.6% |
| Nausea |
6.0% |
| Toothache |
5.5% |
| Wound |
4.4% |
| Malaise |
3.8% |
| Osteonecrosis |
3.8% |
| Pain In Extremity |
3.8% |
| Tendonitis |
3.8% |
| Tooth Fracture |
3.8% |
| Unevaluable Event |
3.8% |
| Urinary Retention |
3.8% |
| Vision Blurred |
3.8% |
| Dyspnoea |
3.3% |
| Fatigue |
3.3% |
| Pain |
3.3% |
| Suicidal Ideation |
3.3% |
| Throat Irritation |
3.3% |
|
| Interacting |
| Supplementation Therapy |
40.0% |
| Menopause |
20.0% |
| Thyroid Disorder |
20.0% |
| Herpes Zoster |
10.0% |
| Hormone Therapy |
10.0% |
|
| Fluid Retention |
50.0% |
| Unevaluable Event |
50.0% |
|
